Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构：
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1685 / 1692
页数：7
相关论文
共 50 条
  • [1] Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Guo, Tian-Kang
    Hao, Xiang-Yong
    Ma, Bin
    Yang, Ke-Hu
    Li, Yi-Ping
    Li, Hong-Ling
    Gu, Yuan-Hui
    Cai, Hui
    Liu, Ya-Li
    Li, Yuan
    Zhan, Wei-Peng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1685 - 1692
  • [2] Efficacy of treatment regimens for advanced hepatocellular carcinoma A network meta-analysis of randomized controlled trials
    Chen, Qi-Feng
    Wu, Pei-Hong
    Huang, Tao
    Shen, Lu-Jun
    Huang, Zi-Lin
    Li, Wang
    MEDICINE, 2019, 98 (40)
  • [3] An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma
    Peng, Songlin
    Zhao, Yang
    Xu, Feng
    Jia, Changjun
    Xu, Yongqing
    Dai, Chaoliu
    PLOS ONE, 2014, 9 (12):
  • [4] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [5] Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials
    Cammà, C
    Schepis, F
    Orlando, A
    Albanese, M
    Shahied, L
    Trevisani, F
    Andreone, P
    Craxì, A
    Cottone, M
    RADIOLOGY, 2002, 224 (01) : 47 - 54
  • [6] Octreotide for improving survival in patients with advanced hepatocellular carcinoma: a meta-analysis
    Estanislao, N. I.
    Ang, E.
    Flores, H.
    Salvana, A.
    Tripon, E.
    Velasquez, M. E.
    Ong, J. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A155 - A155
  • [7] Chemotherapy for advanced biliary tract carcinoma A meta-analysis of randomized controlled trials
    Chen, Lawrence
    Chen, Chiehfeng
    Yen, Yun
    Tam, Ka-Wai
    MEDICINE, 2016, 95 (33)
  • [8] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [9] Current Treatments for Small Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials
    Guo, Z.
    Zheng, Z.
    He, X.
    Chen, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 213 - 213
  • [10] Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials
    Lu, Fenping
    Zhao, Kai
    Ye, Miaoqing
    Xing, Guangyan
    Liu, Bowen
    Li, Xiaobin
    Ran, Yun
    Wu, Fenfang
    Chen, Wei
    Hu, Shiping
    BMC CANCER, 2024, 24 (01)
12345